Elmunzer B Joseph, Noureldin Mohamed, Morgan Katherine A, Adams David B, Coté Gregory A, Waljee Akbar K
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA.
Am J Gastroenterol. 2017 Oct;112(10):1596-1602. doi: 10.1038/ajg.2017.247. Epub 2017 Aug 15.
Cholecystectomy after endoscopic sphincterotomy (ES) is associated with improved outcomes compared to ES alone, however randomized trials have included mainly fit surgical candidates. Our objective was to assess the impact of cholecystectomy after ES among elderly patients, in whom the perceived risks of surgery may be increased and the prevailing bias may be to defer cholecystectomy.
We performed adjusted analyses comparing clinical outcomes in patients ≥65 years of age who did and did not undergo follow-up cholecystectomy after endoscopic sphincterotomy for choledocholithiasis, ascending cholangitis, or gallstone pancreatitis. We also compared adverse events between the two groups.
In the ES alone group, 39.3% of patients experienced a recurrent complication compared with 18.0% in the ES and cholecystectomy group. After adjusting for comorbidities using multivariable regression, cholecystectomy in addition to ES was associated with a reduced risk of recurrent choledocholithiasis (OR 0.38, 95%CI 0.34-0.42, P<0.001), ascending cholangitis (OR 0.28, 95%CI 0.23-0.34, P<0.001), and gallstone pancreatitis (OR 0.35, 95%CI 0.24-0.49, P<0.001) compared to ES alone. This benefit was preserved after propensity score adjustment, in patients ≥75 years of age, and in those with major comorbidities including cancer, heart failure, and liver disease. Serious post-operative complications such as myocardial infarction, pulmonary embolism, and pneumonia were not more common in the cholecystectomy group.
Among older patients, including those with serious comorbidities, cholecystectomy after endoscopic sphincterotomy was associated with a significant and clinically important reduction in recurrent complications compared to sphincterotomy alone. This benefit did not appear to be outweighed by surgical complications, highlighting the importance of cholecystectomy, even in elderly patients whose lifespans may be limited by unrelated conditions.
与单纯内镜括约肌切开术(ES)相比,内镜括约肌切开术后行胆囊切除术的疗效更佳,但随机试验纳入的主要是适合手术的患者。我们的目的是评估内镜括约肌切开术后行胆囊切除术对老年患者的影响,这类患者手术风险可能增加,普遍存在推迟胆囊切除术的倾向。
我们进行了校正分析,比较年龄≥65岁、因胆总管结石、化脓性胆管炎或胆源性胰腺炎行内镜括约肌切开术后未接受和接受随访胆囊切除术患者的临床结局。我们还比较了两组的不良事件。
单纯内镜括约肌切开术组中,39.3%的患者出现复发性并发症,而行内镜括约肌切开术加胆囊切除术组为18.0%。使用多变量回归校正合并症后,与单纯内镜括约肌切开术相比,内镜括约肌切开术加胆囊切除术可降低胆总管结石复发风险(比值比[OR]0.38,95%置信区间[CI]0.34 - 0.42,P<0.001)、化脓性胆管炎复发风险(OR 0.28,95%CI 0.23 - 0.34,P<0.001)和胆源性胰腺炎复发风险(OR 0.35,95%CI 0.24 - 0.49,P<0.001)。在倾向评分校正后、75岁及以上患者以及患有包括癌症、心力衰竭和肝病在内的主要合并症的患者中,这种益处依然存在。心肌梗死、肺栓塞和肺炎等严重术后并发症在胆囊切除术组中并不更常见。
在老年患者中,包括患有严重合并症的患者,与单纯括约肌切开术相比,内镜括约肌切开术后行胆囊切除术可显著且在临床上大幅降低复发性并发症。这种益处似乎并未被手术并发症所抵消,这凸显了胆囊切除术的重要性,即使是在寿命可能受无关疾病限制的老年患者中。